Related Experiment Videos
Ifosfamide in testicular cancer
1Department of Medicine, Indiana University School of Medicine, Indianapolis.
Seminars in Oncology
|April 1, 1990
Summary
Ifosfamide shows promise as a salvage therapy for testicular tumors resistant to cisplatin. It offers objective responses as a single agent and high remission rates in combination therapy for recurrent germ cell tumors.
Area of Science:
- Oncology
- Medical Chemistry
Background:
- Testicular tumors often become refractory to standard cisplatin-based chemotherapy.
- Salvage therapy is crucial for patients with treatment-resistant or recurrent germ cell tumors.
Purpose of the Study:
- To evaluate the efficacy of ifosfamide as a salvage treatment for testicular tumors.
- To assess ifosfamide's role in combination regimens for recurrent germ cell tumors.
Main Methods:
- Review of clinical data on ifosfamide use in refractory testicular cancer.
- Analysis of response rates for single-agent and combination ifosfamide therapy.
Main Results:
- Ifosfamide as a single agent yields objective responses in about 20% of heavily pretreated patients.
- Combination therapy including ifosfamide achieves complete remission in 40-50% of pretreated patients with recurrent germ cell tumors.
Conclusions:
- Ifosfamide is an active agent in salvage settings for testicular neoplasms.
- Further research is needed to define ifosfamide's optimal role, potentially in initial induction therapy.